Pharmaceutical companies seeking tie-ups over development of anti-obesity drugs

Published: 2011-08-30 06:59:00

Updated: 2011-08-30 06:59:00

Now that the prevalence of obesity has been increasing at an alarming rate over the past few years, not only in the industrialized nations, but also in the developing ones, the focus of government agencies and pharmaceutical companies is on establishing preventive programs and developing anti-obe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK